VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ASPNAspen Aerogels, Inc.
$6.32$524M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ASPN logoAspen Aerogels, Inc.(ASPN)Earnings, Financials & Key Ratios

ASPN•NYSE
Price updated Jun 19, 2026
SectorIndustrialsIndustryConstructionSub-IndustryBuilding envelope and openings
AboutAspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.Show more
  • Revenue$271M-40.1%
  • EBITDA-$6M-107.9%
  • Net Income-$390M-3012.5%
  • EPS (Diluted)-4.74-2888.2%
  • Gross Margin16.97%-58.0%
  • EBITDA Margin-2.3%-113.2%
  • Operating Margin-18.96%-257.4%
  • Net Margin-143.69%-4963.5%
  • ROE-91.64%-3877.7%

ASPN Key Insights

Aspen Aerogels, Inc. (ASPN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 93 (top 7%)
  • ✓Strong 5Y sales CAGR of 22.0%

✗Weaknesses

  • ✗Profits declining 78.0% over 5 years
  • ✗Negative free cash flow
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ASPN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ASPN Price & Volume

Aspen Aerogels, Inc. (ASPN) stock price & volume — 10-year historical chart

Loading chart...

ASPN Growth Metrics

Aspen Aerogels, Inc. (ASPN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.27%
5 Years22.01%
3 Years14.55%
TTM-47.3%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM60.85%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM61.03%

Return on Capital

10 Years-17.87%
5 Years-13.45%
3 Years-3.21%
Last Year-9.1%

ASPN Recent Earnings

Aspen Aerogels, Inc. (ASPN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.28-3.7%
$0.27
Rev
$38M+3.6%
$37M
Q1 2026
Feb 25, 2026
Metric
Actual
Est
EPS
$0.34-25.9%
$0.27
Rev
$41M-6.7%
$44M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.06+72.1%
$0.21
Rev
$73M+64.4%
$44M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.04+66.7%
$0.12
Rev
$78M+10.7%
$70M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.28vs $0.27-3.7%
$38Mvs $37M+3.6%
Q1 2026Feb 25, 2026
$0.34vs $0.27-25.9%
$41Mvs $44M-6.7%
Q4 2025Nov 6, 2025
$0.06vs $0.21+72.1%
$73Mvs $44M+64.4%
Q3 2025Aug 7, 2025
$0.04vs $0.12+66.7%
$78Mvs $70M+10.7%
Based on last 12 quarters of dataView full earnings history →

ASPN Peer Comparison

Aspen Aerogels, Inc. (ASPN) competitors in Building envelope and openings — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
KALU logoKALUKaiser Aluminum CorporationDirect Competitor2.96B182.7526.9911.54%4.14%18.68%1.36
UFPI logoUFPIUFP Industries, Inc.Direct Competitor4.92B86.5817.32-4.99%4.27%8.41%0.07
MTRN logoMTRNMaterion CorporationDirect Competitor5.72B274.9876.816.05%3.99%8.17%0.64
OC logoOCOwens CorningProduct Competitor10.32B128.14-20.47-7.95%-5.42%-12.38%1.58
AWI logoAWIArmstrong World Industries, Inc.Product Competitor6.74B157.8822.3012.11%18.59%34.81%0.59
IBP logoIBPInstalled Building Products, Inc.Product Competitor5.88B218.2522.481%8.65%37.46%1.48
ROCK logoROCKGibraltar Industries, Inc.Product Competitor1.21B40.9012.58-13.24%0.75%0.94%0.11
JELD logoJELDJELD-WEN Holding, Inc.Product Competitor153.62M1.78-0.25-14.95%-16.09%-291.23%15.81

Compare ASPN vs Peers

Aspen Aerogels, Inc. (ASPN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs KALU

Most directly comparable listed peer for ASPN.

Scale Benchmark

vs TSLA

Larger-name benchmark to compare ASPN against a more recognizable public peer.

Peer Set

Compare Top 5

vs KALU, UFPI, MTRN, OC

ASPN Income Statement

Aspen Aerogels, Inc. (ASPN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
111.63M104.36M139.38M100.27M121.62M180.36M238.72M452.7M271.1M230.26M
Revenue Growth %
-5.19%-6.51%33.55%-28.06%21.29%48.3%32.35%89.64%-40.11%-47.3%
Cost of Goods Sold
92.96M91.69M113.09M85.68M111.69M175.39M181.8M269.8M225.1M202.8M
COGS % of Revenue
83.27%87.86%81.14%85.45%91.83%97.24%76.16%59.6%83.03%-
Gross Profit
18.67M▲ 0%
12.67M▼ 32.1%
26.28M▲ 107.5%
14.59M▼ 44.5%
9.94M▼ 31.9%
4.98M▼ 49.9%
56.92M▲ 1043.9%
182.9M▲ 221.3%
46M▼ 74.9%
27.46M▲ 0%
Gross Margin %
16.73%12.14%18.86%14.55%8.17%2.76%23.84%40.4%16.97%11.93%
Gross Profit Growth %
-19.9%-32.15%107.47%-44.48%-31.91%-49.92%1043.91%221.32%-74.85%-
Operating Expenses
37.81M39.23M40.44M36.16M50.54M84.22M106.12M128.36M97.39M-200.08M
OpEx % of Revenue
33.87%37.59%29.02%36.06%41.55%46.7%44.46%28.35%35.92%-
Selling, General & Admin
31.63M32.91M32.04M27.43M39.09M67.29M89.77M106.8M40.91B84.52M
SG&A % of Revenue
28.33%31.53%22.99%27.36%32.14%37.31%37.6%23.59%15090.98%-
Research & Development
6.18M6.32M8.41M8.73M11.44M16.93M16.36M18.05M6.3B11.81M
R&D % of Revenue
5.54%6.05%6.03%8.71%9.41%9.39%6.85%3.99%2322.04%-
Other Operating Expenses
00000003.51M-47.11B1000K
Operating Income
-19.14M▲ 0%
-33.92M▼ 77.2%
-14.16M▲ 58.3%
-21.57M▼ 52.3%
-40.6M▼ 88.2%
-79.25M▼ 95.2%
-49.2M▲ 37.9%
54.53M▲ 210.8%
-51.39M▼ 194.2%
227.54M▲ 0%
Operating Margin %
-17.14%-32.5%-10.16%-21.51%-33.38%-43.94%-20.61%12.05%-18.96%98.82%
Operating Income Growth %
-70.55%-77.24%58.25%-52.33%-88.23%-95.19%37.91%210.84%-194.24%-
EBITDA
-8.38M-23.13M-3.95M-11.37M-31.16M-70.02M-31.03M78.95M-6.24M273.36M
EBITDA Margin %
-7.51%-22.16%-2.83%-11.34%-25.62%-38.82%-13%17.44%-2.3%118.72%
EBITDA Growth %
-513.24%-175.9%82.94%-188.17%-174.02%-124.73%55.69%354.45%-107.9%221.65%
D&A (Non-Cash Add-back)
10.75M10.79M10.21M10.2M9.44M9.22M18.18M24.41M45.16M45.82M
EBIT
-19.14M-33.92M-14.16M-21.57M-36.87M-77.63M-40.48M27.05M5.67B-98.64M
Net Interest Income
-185K-524K-406K-240K-229K-3.49M1.21M-11.96M-6.06B-5.6M
Interest Income
000001.62M6.53M000
Interest Expense
185K524K406K240K229K5.11M5.33M11.96M6.06B5.6M
Other Income/Expense
-185K-524K-406K-240K3.5M-3.49M3.39M-39.45M-335.77M-338.47M
Pretax Income
-19.32M▲ 0%
-34.44M▼ 78.3%
-14.56M▲ 57.7%
-21.81M▼ 49.7%
-37.09M▼ 70.1%
-82.74M▼ 123.0%
-45.81M▲ 44.6%
15.09M▲ 132.9%
-387.16M▼ 2665.8%
-110.93M▲ 0%
Pretax Margin %
-17.31%-33%-10.45%-21.75%-30.5%-45.87%-19.19%3.33%-142.81%-48.17%
Income Tax
00000001.71M2.39M1.06M
Effective Tax Rate %
0%0%0%0%0%0%0%11.36%-0.62%-0.96%
Net Income
-19.32M▲ 0%
-34.44M▼ 78.3%
-14.56M▲ 57.7%
-21.81M▼ 49.7%
-37.09M▼ 70.1%
-82.74M▼ 123.0%
-45.81M▲ 44.6%
13.38M▲ 129.2%
-389.55M▼ 3012.5%
-111.99M▲ 0%
Net Margin %
-17.31%-33%-10.45%-21.75%-30.5%-45.87%-19.19%2.95%-143.69%-48.64%
Net Income Growth %
-60.7%-78.25%57.71%-49.74%-70.09%-123.05%44.63%129.2%-3012.54%60.85%
Net Income (Continuing)
-19.32M-34.44M-14.56M-21.81M-37.09M-82.74M-45.81M13.38M-389.55M-111.99M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.83▲ 0%
-1.45▼ 74.7%
-0.20▲ 86.2%
-0.45▼ 125.0%
-0.92▼ 104.4%
-2.19▼ 138.0%
-0.66▲ 69.9%
0.17▲ 125.8%
-4.74▼ 2888.2%
-1.35▲ 0%
EPS Growth %
-59.62%-74.7%86.21%-125%-104.44%-138.04%69.86%125.76%-2888.24%61.03%
EPS (Basic)
-0.83-1.45-0.20-0.45-0.92-2.19-0.660.17-4.74-
Diluted Shares Outstanding
23.39M23.74M24.1M26.38M30.43M39.36M69.44M80.31M82.66M82.74M
Basic Shares Outstanding
23.39M23.74M24.1M26.38M30.43M39.36M69.44M77.53M82.66M82.74M
Dividend Payout Ratio
----------

ASPN Balance Sheet

Aspen Aerogels, Inc. (ASPN) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
47.66M37.25M45.77M47.12M112.15M369.69M266.33M409.45M242.05M252.55M
Cash & Short-Term Investments
10.69M3.33M3.63M16.5M76.56M281.33M139.72M220.88M156.86M175.58M
Cash Only
10.69M3.33M3.63M16.5M76.56M281.33M139.72M220.88M156.86M175.58M
Short-Term Investments
0000000000
Accounts Receivable
26.76M25.57M32.25M15.7M20.43M57.35M70M109.1M35.27M36.44M
Days Sales Outstanding
87.5189.4184.4757.1461.3116.06107.0287.9747.4986
Inventory
8.91M7.32M8.77M13.1M11.99M22.54M39.19M47.55M38.25M31.05M
Days Inventory Outstanding
3529.1328.355.839.1746.978.6864.3362.0274
Other Current Assets
1.29M1.04M1.11M008.46M17.42M31.91M11.68M9.47M
Total Non-Current Assets
76.15M61.77M57.73M50.3M70.8M273.73M436.72M485.7M164.63M157.93M
Property, Plant & Equipment
76.07M61.7M57.65M50.22M69.31M271.21M434.44M480.13M122.55M116.62M
Fixed Asset Turnover
1.47x1.69x2.42x2.00x1.75x0.67x0.55x0.94x2.21x1.54x
Goodwill
0000000000
Intangible Assets
0000000000
Long-Term Investments
0000000000
Other Non-Current Assets
86K73K84K84K1.5M2.52M2.28M5.57M42.08M41.31M
Total Assets
123.81M▲ 0%
99.02M▼ 20.0%
103.5M▲ 4.5%
97.42M▼ 5.9%
182.95M▲ 87.8%
643.42M▲ 251.7%
703.05M▲ 9.3%
895.14M▲ 27.3%
406.68M▼ 54.6%
410.48M▲ 0%
Asset Turnover
0.90x1.05x1.35x1.03x0.66x0.28x0.34x0.51x0.67x0.50x
Asset Growth %
-8.06%-20.02%4.52%-5.87%87.79%251.68%9.27%27.32%-54.57%-147.67%
Total Current Liabilities
21.57M23.07M30.43M13.93M36.55M78.94M78.09M110.11M62.02M87.8M
Accounts Payable
10.65M12.39M12.6M5.35M17.44M54.73M51.09M44.36M13.24M13.61M
Days Payables Outstanding
41.8349.3340.6522.857113.89102.5860.0121.4732.83
Short-Term Debt
3.75M4.18M3.12M1.61M00023.78M34.57M34.25M
Deferred Revenue (Current)
1.3M2.63M5.62M2.04M6.05M5.85M2.32M2.2M1.26M23.85M
Other Current Liabilities
1.23M1.11M1.58M2.59M8.99M12.47M16.88M19.37M12.95M11.74M
Current Ratio
2.21x1.61x1.50x3.38x3.07x4.68x3.41x3.72x3.90x2.88x
Quick Ratio
1.80x1.30x1.22x2.44x2.74x4.40x2.91x3.29x3.29x2.52x
Cash Conversion Cycle
80.6969.2172.1190.1543.4849.0783.1292.2888.03127.17
Total Non-Current Liabilities
1.3M5.7M14.08M15.64M17.99M117.04M136.9M170.33M109.14M109.18M
Long-Term Debt
0002.06M0103.58M114.99M137.09M79.8M68.31M
Capital Lease Obligations
004.29M3.6M12.99M13.46M21.91M33.23M29.34M118.24M
Deferred Tax Liabilities
00-9.79M434K000000
Other Non-Current Liabilities
1.3M5.7M9.79M0000000
Total Liabilities
22.87M28.77M44.51M29.57M54.55M195.98M214.99M280.44M171.16M196.98M
Total Debt
3.75M4.18M8.45M8.31M15.24M119.4M138.77M197.38M143.71M128.82M
Net Debt
-6.94M854K4.82M-8.19M-61.33M-161.93M-951K-23.5M-13.15M-46.76M
Debt / Equity
0.04x0.06x0.14x0.12x0.12x0.27x0.28x0.32x0.61x0.60x
Debt / EBITDA
-------2.50x-0.47x
Net Debt / EBITDA
--------0.30x--0.17x
Interest Coverage
-103.44x-64.73x-34.87x-89.87x-160.98x-15.19x-7.60x2.26x0.94x-17.60x
Total Equity
100.94M▲ 0%
70.25M▼ 30.4%
58.99M▼ 16.0%
67.85M▲ 15.0%
128.41M▲ 89.2%
447.44M▲ 248.4%
488.06M▲ 9.1%
614.71M▲ 25.9%
235.52M▼ 61.7%
213.5M▲ 0%
Equity Growth %
-12.65%-30.4%-16.03%15.02%89.25%248.45%9.08%25.95%-61.69%-174.02%
Book Value per Share
4.322.962.452.574.2211.377.037.652.852.58
Total Shareholders' Equity
100.94M70.25M58.99M67.85M128.41M447.44M488.06M614.71M235.52M213.5M
Common Stock
0000000000
Retained Earnings
-437.14M-471.58M-486.15M-507.96M-545.05M-627.79M-673.6M-660.23M-1.05B-1.07B
Treasury Stock
0000000000
Accumulated OCI
-82.53M-92.7M00000000
Minority Interest
0000000000

ASPN Cash Flow Statement

Aspen Aerogels, Inc. (ASPN) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-4.61M-8.65M-1.05M-9.92M-18.63M-94.4M-42.61M45.55M32.87M61.38M
Operating CF Margin %
-4.13%-8.29%-0.76%-9.9%-15.32%-52.34%-17.85%10.06%12.13%-
Operating CF Growth %
-696.89%-87.89%87.82%-841.56%-87.71%-406.76%54.86%206.89%-27.83%266.44%
Net Income
-19.32M-34.44M-14.56M-21.81M-37.09M-82.74M-45.81M13.38M-389.55M-111.99M
Depreciation & Amortization
10.75M10.79M10.21M10.2M9.44M9.22M18.18M22.53M45.16M19.48M
Stock-Based Compensation
5.09M4.3M3.77M5M5.18M9.38M012.86M8.63M5.85M
Deferred Taxes
010.28M0325K-3.82M0000-522K
Other Non-Cash Items
-112K-121K947K980K1.64M7.9M16.19M47.75M320.08M-23.68M
Working Capital Changes
-1.02M540K-1.42M-4.62M6.03M-38.16M-31.17M-50.96M48.56M99.33M
Change in Receivables
-8.7M-1.72M-6.69M16.23M-4.64M-37.04M-12.55M-39.36M70.3M37.27M
Change in Inventory
3.95M1.6M-1.45M-4.33M1.11M-10.55M-16.65M-8.36M9.3M25.68M
Change in Payables
1.27M1.56M141K-7.15M7.38M5.32M4.58M7.34M-19.45M-2.28M
Cash from Investing
-6.12M-3.59M-2.11M-3.42M-13.78M-177.97M-175.46M-86.26M-37.45M-25.82M
Capital Expenditures
-6.12M-3.59M-2.11M-3.42M-13.78M-177.97M-175.46M-86.26M-37.45M-25.82M
CapEx % of Revenue
5.48%3.44%1.52%3.41%11.33%98.67%73.5%19.05%13.81%11.21%
Acquisitions
0000000000
Investments
----------
Other Investing
0000000000
Cash from Financing
3.33M4.88M3.47M26.2M92.47M478.37M75.48M122.02M-58.13M-52.42M
Debt Issued (Net)
3.72M431K-1.06M563K0100M-623K25.59M-59.23M-53.9M
Equity Issued (Net)
0-551K024.71M94.42M391.3M76.52M93.84M1.87M363K
Dividends Paid
0000000000
Share Repurchases
-391K-551K0000000-115K
Other Financing
-391K5M4.53M931K-1.95M-12.93M-420K2.59M-765K1.12M
Net Change in Cash
-7.39M▲ 0%
-7.37M▲ 0.3%
306K▲ 104.2%
12.86M▲ 4103.6%
60.07M▲ 367.0%
206M▲ 242.9%
-142.59M▼ 169.2%
81.31M▲ 157.0%
-62.71M▼ 177.1%
-16.85M▲ 0%
Free Cash Flow
-10.72M▲ 0%
-12.25M▼ 14.2%
-3.17M▲ 74.1%
-13.34M▼ 321.4%
-32.41M▼ 142.9%
-272.37M▼ 740.5%
-218.07M▲ 19.9%
-40.71M▲ 81.3%
-4.58M▲ 88.8%
35.57M▲ 0%
FCF Margin %
-9.61%-11.74%-2.27%-13.3%-26.64%-151.01%-91.35%-8.99%-1.69%15.45%
FCF Growth %
22.26%-14.2%74.15%-321.35%-142.92%-740.5%19.94%81.33%88.76%896.22%
FCF per Share
-0.46-0.52-0.13-0.51-1.06-6.92-3.14-0.51-0.060.43
FCF Conversion (FCF/Net Income)
0.24x0.25x0.07x0.46x0.50x1.14x0.93x3.41x-0.08x-0.32x
Interest Paid
00440K0000008.84M
Taxes Paid
000000000402K

ASPN Key Ratios

Aspen Aerogels, Inc. (ASPN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-17.85%-40.23%-22.54%-34.39%-37.8%-28.74%-9.79%2.43%-91.64%-42.12%
Return on Invested Capital (ROIC)
-14.99%-30.81%-15.74%-26.2%-48.05%-33.71%-9.55%7.59%-9.48%67.68%
Gross Margin
16.73%12.14%18.86%14.55%8.17%2.76%23.84%40.4%16.97%11.93%
Net Margin
-17.31%-33%-10.45%-21.75%-30.5%-45.87%-19.19%2.95%-143.69%-48.64%
Debt / Equity
0.04x0.06x0.14x0.12x0.12x0.27x0.28x0.32x0.61x0.60x
Interest Coverage
-103.44x-64.73x-34.87x-89.87x-160.98x-15.19x-7.60x2.26x0.94x-17.60x
FCF Conversion
0.24x0.25x0.07x0.46x0.50x1.14x0.93x3.41x-0.08x-0.32x
Revenue Growth
-5.19%-6.51%33.55%-28.06%21.29%48.3%32.35%89.64%-40.11%-47.3%
Related:ASPN Dividend History·ASPN Revenue History·ASPN Price History·ASPN P/E History·ASPN Financial Ratios·ASPN Institutional Holders

ASPN SEC Filings & Documents

Aspen Aerogels, Inc. (ASPN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Apr 21, 2026·SEC

Material company update

Feb 25, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 13, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Mar 7, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

ASPN Frequently Asked Questions

Aspen Aerogels, Inc. (ASPN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Aspen Aerogels, Inc. (ASPN) reported $230.3M in revenue for fiscal year 2025. This represents a 705% increase from $28.6M in 2009.

Aspen Aerogels, Inc. (ASPN) saw revenue decline by 40.1% over the past year.

Aspen Aerogels, Inc. (ASPN) reported a net loss of $112.0M for fiscal year 2025.

Dividend & Returns

Aspen Aerogels, Inc. (ASPN) has a return on equity (ROE) of -91.6%. Negative ROE indicates the company is unprofitable.

Aspen Aerogels, Inc. (ASPN) generated $35.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ASPN back in 2009?

Total return calculator · dividends reinvested · 17+ years of data

See returns →

How much would $100/month in ASPN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →